Resources » Extended Half-Life (EHL) Factor Therapy
LINKS
DETAILS

Year: 2023

Language: English

This resource is also available in: French Spanish

Author(s): World Federation of Hemophilia

Format: Video

Extended Half-Life (EHL) Factor Therapy

ADDITIONAL INFORMATION

This video gives a quick introduction to extended half-life (EHL) clotting factor replacement therapy.

Learn more about different treatment options for hemophilia with the World Federation of Hemophilia Shared Decision Making tool!

The WFH does not engage in the practice of medicine and under no circumstances recommends particular treatment for specific individuals. For diagnosis or consultation on a specific medical problem, the WFH recommends that you contact your physician or local treatment centre. Before administering any products, the WFH urges patients to check dosages with a physician or hemophilia centre staff, and to consult the pharmaceutical company’s printed instructions.

The WFH does not promote any particular pharmaceutical product and any mention of any commercial brand in this presentation is strictly for educational purposes.

RELATED RESOURCES

Documents and PDFs

Economic Benefits of Basic Hemophilia Treatment & Care – Japanese

Also Available In: English, Spanish, French, Arabic, Russian, Simplified Chinese このファクトシートには、血友病患者に基本的な治療およびケアを提供するメリットが記載されています。適切なケアには、血友病治療センターおよび治療用製剤の利用、医療関係者、患者、家族に対する教育が含まれます。

Read More >
Documents and PDFs

Benefits of Treating Hemophilia with Factor Concentrate – Japanese

Also Available In: English, Spanish, French, Arabic, Russian, Simplified Chinese 安全で規制を順守している血漿由来凝固因子濃縮製剤で血友病患者を治療することは、出血性疾患患者への社会経済的影響、さらには政府やコミュニティ、家族から求められる長期的支援を直接軽減します。

Read More >
Copy resource link